Transcranial Magnetic Stimulation (TMS) in the Treatment of Anorexia Nervosa
NCT: NCT05368844 · TERMINATED
Brief Summary
Anorexia nervosa is a severe psychiatric disorder associated with food avoidance and body image distortion, that is feeling fat despite being underweight. It is the third most common chronic illness among adolescent females, and its mortality reaches its peak between the ages 16 and 29 years old. There are very few treatments for anorexia nervosa and especially no biological treatments have been approved. Recent brain imaging research has repeatedly implicated brain circuits that include the insula in the disorder. The insula is a brain region important in taste processing as well as in the integration of body perception and has strong connections to the brain reward system. Transcranial magnetic stimulation (TMS) is a relatively new methodology that has been shown to alter neurocircuitry and alleviate depression. Here, the study goal is to develop TMS as a methodology to change altered neurocircuitry in anorexia nervosa and alleviate disorder specific behaviors.
Frequently Asked Questions
What is Transcranial Magnetic Stimulation (TMS) in the Treatment of Anorexia Nervosa?
Transcranial Magnetic Stimulation (TMS) in the Treatment of Anorexia Nervosa is a clinical trial registered under NCT05368844. Current status: TERMINATED.
What is the status of NCT05368844?
The current status of NCT05368844 (Transcranial Magnetic Stimulation (TMS) in the Treatment of Anorexia Nervosa) is: TERMINATED.
When did Transcranial Magnetic Stimulation (TMS) in the Treatment of Anorexia Nervosa start?
Transcranial Magnetic Stimulation (TMS) in the Treatment of Anorexia Nervosa started on 2022-06-16.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.